<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05049785</url>
  </required_header>
  <id_info>
    <org_study_id>2010-0654</org_study_id>
    <secondary_id>NCI-2019-02456</secondary_id>
    <secondary_id>2010-0654</secondary_id>
    <nct_id>NCT05049785</nct_id>
  </id_info>
  <brief_title>Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone</brief_title>
  <official_title>Nutrition Intervention for Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how well a nutrition and physical activity intervention works in&#xD;
      preventing excess weight gain in pediatric patients with leukemia or lymphoma treated with&#xD;
      Treated with prednisone and/or dexamethasone. A nutrition and physical activity intervention&#xD;
      may help develop healthier eating habits and prevent rapid excess weight gain in pediatric&#xD;
      patients with leukemia or lymphoma who are receiving prednisone and/or dexamethasone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To evaluate if a nutrition counseling intervention will prevent an increase in waist&#xD;
      circumference from baseline measurements for children/adolescents diagnosed with leukemia or&#xD;
      lymphoma and being treated with prednisone and/or dexamethasone.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To conduct qualitative research on diet habits, likeability of low-fat and-low sucrose&#xD;
      foods.&#xD;
&#xD;
      II. To conduct qualitative research on exercise habits and willingness to engage in moderate&#xD;
      walking.&#xD;
&#xD;
      III. To assess receptivity to electronic dietary and physical activity (PA) interventions in&#xD;
      pediatric cancer patients and survivors (PCPSs) and their parents.&#xD;
&#xD;
      IV. To determine if nutrition interventions will prevent an increase in body mass index (BMI)&#xD;
      from baseline measurements for children/adolescents diagnosed with leukemia or lymphoma and&#xD;
      being treated with prednisone and/or dexamethasone.&#xD;
&#xD;
      V. To determine if a nutrition counseling intervention will help maintain or decrease&#xD;
      triglyceride and cholesterol levels, prevent abnormal values of hemoglobin A1C and improve&#xD;
      absolute lymphocyte counts (ALC) from baseline measurements for pediatric leukemia or&#xD;
      lymphoma patients, receiving prednisone and/or dexamethasone therapy.&#xD;
&#xD;
      VI. To evaluate caloric intake, nutritional parameters and oxidative stress in pediatric&#xD;
      leukemia or lymphoma patients receiving prednisone and/or dexamethasone therapy.&#xD;
&#xD;
      VII. To evaluate responses to various energy balance interventions.&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 2 arms.&#xD;
&#xD;
      ARM I: Patients attend 13 nutrition counseling sessions over 45 minutes each for 1 year.&#xD;
      Patients may receive nutrition handouts.&#xD;
&#xD;
      ARM II: Patients attend 2 tasting sessions for low-fat and low-sugar recipes and complete 2&#xD;
      PA sessions over 1 hour for each session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 12, 2011</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in waist circumference</measure>
    <time_frame>through study completion an average of 1 year</time_frame>
    <description>Will assess the difference in waist circumferences between patients in the Arm 1 intervention group compared to patients in the Arm 1 control group. The primary analysis will use the two-sample t-tests, and will be conducted on the intent-to-treat basis. This implies that if patients in the control arm received nutrition counseling, that patient will still be labeled as control.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Leukemia</condition>
  <condition>Lymphoma</condition>
  <arm_group>
    <arm_group_label>Arm I (counseling)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients attend 13 nutrition counseling sessions over 45 minutes each for 1 year. Patients may receive nutrition handouts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (nutrition and PA intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients attend 2 tasting sessions for low-fat and low-sugar recipes and complete 2 PA sessions over 1 hour for each session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Counseling</intervention_name>
    <description>Attend nutrition counseling sessions</description>
    <arm_group_label>Arm I (counseling)</arm_group_label>
    <other_name>Counseling Intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <description>Complete PA sessions</description>
    <arm_group_label>Arm II (nutrition and PA intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Informational Intervention</intervention_name>
    <description>Receive nutrition handouts</description>
    <arm_group_label>Arm I (counseling)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional Intervention</intervention_name>
    <description>Attend tasting sessions</description>
    <arm_group_label>Arm II (nutrition and PA intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (counseling)</arm_group_label>
    <arm_group_label>Arm II (nutrition and PA intervention)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Leukemia or lymphoma patient at MD Anderson Children's Cancer Hospital&#xD;
&#xD;
          -  Patients receiving prednisone and/or dexamethasone therapy at MD Anderson Children's&#xD;
             Cancer Hospital at time of enrollment&#xD;
&#xD;
          -  Karnofsky performance status greater than or equal to 70&#xD;
&#xD;
          -  Must be cleared by treating oncologist to participate in study&#xD;
&#xD;
          -  Must live close enough to attend measurement sessions at one of the clinical centers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients receiving nutrition counseling or weight management counseling elsewhere&#xD;
&#xD;
          -  Pediatric patients who are already receiving steroids that are not part of treatment&#xD;
&#xD;
          -  History of psychological disorders as indicated in the medical record (eg: eating&#xD;
             disorders, depression)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joya Chandra</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>M D Anderson Cancer Center website</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

